This event is co-organised by Pantai Premier Pathology and QIAGEN.
According to “Stop TB Partnership”, Tuberculosis (TB) remains the world’s biggest infectious disease killer, claiming around 1.5 million people globally every year (1). In Malaysia alone, more than 25,000 new cases of TB were reported in 2018 (2).
A global reduction of 25% in TB detection for 3 months due to the disruption of TB services from the COVID-19 pandemic could result in a 13% increase of TB deaths (3). As a result, we could see an additional 1.4 million TB deaths between 2020 and 2025 (3).
Join us in this live webinar as we discuss how we can best meet the UN’s call to maintain critical TB testing and treatment services during the COVID-19 pandemic response. Register now.
Speakers
 |
|
Dual burden of TB and COVID-19
Dr. Mohd Ihsani Mahmood
TB Leprosy Sector, Disease Control Division
Ministry of Health
|
 |
|
Next chapter in preventing TB – LTBI
Mr. Calvin Sum
Sales Development Manager, SEA
QIAGEN
|
Sources:
(1) Global Cause, https://www.globalcause.co.uk/ending-tb/why-covid-19-means-we-need-to-invest-more-towards-tb-testing/
(2) The Sun Daily, https://www.thesundaily.my/local/tb-deaths-high-due-to-late-treatment-YN1780054
(3) World Health Organisation, https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-covid-19.pdf
